Skip to main content
. 2020 Jan 28;10:1292. doi: 10.1038/s41598-020-58136-x

Table 4.

Comparison of clinical factors between other and LAT1/IGFBP-5 high.

Other LAT1/IGFBP-5 High P
Age (years) 67.95 ± 8.13 69.04 ± 7.88 0.5899
Grade 3 or greater (%) 64.29 96.15 0.0026*
pT stage 3 or greater (%) 53.66 100.00  < 0.0001*
CRP (mg/dL) 1.35 ± 2.38 188 ± 3.26 0.4584
LDH (U/L) 183.06 ± 50.23 219.91 ± 39.60 0.0064*
ALT (IU/L) 15.88 ± 27.45 9.41 ± 5.65 0.2796
AST (IU/L) 18.95 ± 14.21 17.50 ± 6.78 0.6523
ALP (IU/L) 134.93 ± 105.49 136.77 ± 47.43 0.9383
Hb (g/dL) 9.75 ± 1.72 10.10 ± 1.69 0.4259
Alb (U/L) 3.57 ± 1.28 3.31 ± 1.35 0.5007
NLR (ng/mL) 3.10 ± 1.49 4.43 ± 2.06 0.0070*
LAT1 staining score 0.66 ± 0.68 2.22 ± 0.40  < 0.0001*
IGFBP-5 staining score 0.98 ± 0.82 2.40 ± 0.50  < 0.0001*

Data are expressed as mean ± standard deviation unless otherwise indicated. Other = low intensity of the LAT1 and IGFBP-5 immunoreaction and only low intensity of the LAT1 or IGFBP-5 immunoreaction, LAT1/IGFBP-5 High = high intensity of the LAT1 and IGFBP-5 immunoreaction, pT stage = pathological tumour stage, CRP = C-reactive protein, LDH = lactate dehydrogenase, ALT = alanine transaminase, AST = aminotransferase, ALP = alkaline phosphatase, Hb = haemoglobin, Alb = albumin, NLR = neutrophil-to-lymphocyte ratio. *means significant difference.